Surgical Sealants and Adhesives Global Market - Forecast to 2024
Surgical sealants and adhesives are the products used to close the surgical incisions, post surgical application, block the passage of fluids through the surface or openings of the wounds and also to avoid the microbial adhesions and infections. Sealants and Adhesives are usually considered together as they both adhere and seal the surgical incisions. According to IQ4I analysis, the surgical sealants and adhesives global market is expected to grow at high single digit CAGR to reach $3,708.5 million by 2024.
The surgical sealants and adhesives global market is mainly segmented by products, applications, end-users and by geography. The surgical sealants and adhesives global market by the product is segmented into natural and synthetic surgical sealants and adhesives. Natural surgical sealants and adhesives are segmented into fibrin, collagen, gelatin, albumin and others. Synthetic surgical sealants and adhesives are segmented into Cyanoacrylate, hydrogels and others. The application market is segmented into Cardiovascular surgery, General Surgery, Orthopaedic surgery, Urology, Pulmonology, Neurosurgery, Gynecology, Cosmetic surgery and Others applications. The end-users market is segmented into hospitals, ambulatory surgical centres and others.
Some of the major players in Surgical sealants and adhesives market include Baxter International Inc. (U.S.), Johnson & Johnson (Ethicon) (U.S.), Becton, Dickinson & Company (C.R.Bard) (U.S.), B.Braun Melsungen AG (Germany), Medtronic Plc (Ireland), Cryolife, Inc. (U.S.), Mallinckrodt Plc (U.K.), Advanced Medical Solutions Group Plc (U.K.), Takeda Pharmaceutical Company Ltd. (Japan), Cohera Medical, Inc. (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
North America
The surgical sealants and adhesives global market is mainly segmented by products, applications, end-users and by geography. The surgical sealants and adhesives global market by the product is segmented into natural and synthetic surgical sealants and adhesives. Natural surgical sealants and adhesives are segmented into fibrin, collagen, gelatin, albumin and others. Synthetic surgical sealants and adhesives are segmented into Cyanoacrylate, hydrogels and others. The application market is segmented into Cardiovascular surgery, General Surgery, Orthopaedic surgery, Urology, Pulmonology, Neurosurgery, Gynecology, Cosmetic surgery and Others applications. The end-users market is segmented into hospitals, ambulatory surgical centres and others.
Some of the major players in Surgical sealants and adhesives market include Baxter International Inc. (U.S.), Johnson & Johnson (Ethicon) (U.S.), Becton, Dickinson & Company (C.R.Bard) (U.S.), B.Braun Melsungen AG (Germany), Medtronic Plc (Ireland), Cryolife, Inc. (U.S.), Mallinckrodt Plc (U.K.), Advanced Medical Solutions Group Plc (U.K.), Takeda Pharmaceutical Company Ltd. (Japan), Cohera Medical, Inc. (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
North America
- U.S.
- Others
- Germany
- U.K.
- France
- Others
- Japan
- China
- India
- Others
- Brazil
- Rest of Latin America
- Middle East & Others
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing demand for surgical procedures boosts surgical sealants and adhesives market growth
3.3.1.2 Emergence of technically advanced products
3.3.1.3 Acquisition to open an array of opportunities for the market to flourish
3.3.1.4 Increasing geriatric population
3.3.1.5 Acceptance of surgical sealants and adhesives and market expansion in emerging nations
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Pitfalls in usage of surgical sealants and adhesives
3.3.2.2 Expensive surgical sealants and adhesives impeding effective penetration in low and middle income countries
3.3.2.3 Unfavorable reimbursement policies in developing nations
3.3.2.4 Stringent regulatory guidelines
3.3.2.5 Availability of alternative products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 quality management system
3.4.1.2 ISO 14644-1 clean room standards
3.4.1.3 ISO 13485 medical devices
3.4.1.4 ISO 10993 biological evaluation of medical devices
3.4.2 ASTM INTERNATIONAL STANDARDS
3.4.3 U.S.
3.4.4 CANADA
3.4.5 EUROPE
3.4.6 JAPAN
3.4.7 CHINA
3.4.8 INDIA
3.5 CLINICAL TRIALS
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 BARGAINING POWER OF SUPPLIERS
3.6.4 BARGAINING POWER OF BUYERS
3.6.5 RIVALRY AMONG EXISTING COMPETITORS
3.7 SUPPLY CHAIN ANALYSIS
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.9 SURGICAL SEALANTS AND ADHESIVES COMPANY COMPARISON BY PRODUCT TYPE, MATERIAL, PRODUCT NAME AND APPLICATIONS
3.10 MARKET PENETRATION OF SURGICAL SEALANTS AND ADHESIVES IN SURGICAL WOUND CLOSURE MARKET
4 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 NATURAL SURGICAL SEALANTS AND ADHESIVES
4.2.1 FIBRIN
4.2.2 COLLAGEN
4.2.3 GELATIN
4.2.4 ALBUMIN
4.2.5 OTHERS
4.3 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES
4.3.1 CYANOACRYLATE
4.3.2 HYDROGEL
4.3.3 OTHERS
5 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 CARDIOVASCULAR SURGERY
5.3 GENERAL SURGERY
5.4 ORTHOPAEDIC SURGERY
5.5 UROLOGY
5.6 PULMONOLOGY
5.7 NEUROSURGERY
5.8 GYNAECOLOGY
5.9 COSMETIC SURGERY
5.10 OTHERS
6 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTERS
6.4 OTHERS
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 OTHERS
7.3 EUROPE
7.3.1 GERMANY
7.3.2 U.K.
7.3.3 FRANCE
7.3.4 OTHERS
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 OTHERS
7.5 ROW
7.5.1 BRAZIL
7.5.2 REST OF LATIN AMERICA
7.5.3 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 APPROVALS
8.3 AGREEMENT
8.4 ACQUISITIONS
8.5 NEW PRODUCT LAUNCH
8.6 OTHER DEVELOPMENTS
9 MAJOR COMPANIES
9.1 ADVANCED MEDICAL SOLUTIONS GROUP PLC
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 BAXTER INTERNATIONAL, INC
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 B.BRAUN MELSUNGEN AG
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 BECTON, DICKINSON AND COMPANY (C.R.BARD INC.)
9.4.1 OVERVIEW
9.4.2 FINANCIALS*
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 COHERA MEDICAL, INC.
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 CRYOLIFE, INC.
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 JOHNSON & JOHNSON (ETHICON)
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 MALLINCKRODT PLC
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 MEDTRONIC PLC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 TAKEDA PHARMACEUTICAL COMPANY LTD.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing demand for surgical procedures boosts surgical sealants and adhesives market growth
3.3.1.2 Emergence of technically advanced products
3.3.1.3 Acquisition to open an array of opportunities for the market to flourish
3.3.1.4 Increasing geriatric population
3.3.1.5 Acceptance of surgical sealants and adhesives and market expansion in emerging nations
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Pitfalls in usage of surgical sealants and adhesives
3.3.2.2 Expensive surgical sealants and adhesives impeding effective penetration in low and middle income countries
3.3.2.3 Unfavorable reimbursement policies in developing nations
3.3.2.4 Stringent regulatory guidelines
3.3.2.5 Availability of alternative products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 quality management system
3.4.1.2 ISO 14644-1 clean room standards
3.4.1.3 ISO 13485 medical devices
3.4.1.4 ISO 10993 biological evaluation of medical devices
3.4.2 ASTM INTERNATIONAL STANDARDS
3.4.3 U.S.
3.4.4 CANADA
3.4.5 EUROPE
3.4.6 JAPAN
3.4.7 CHINA
3.4.8 INDIA
3.5 CLINICAL TRIALS
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 BARGAINING POWER OF SUPPLIERS
3.6.4 BARGAINING POWER OF BUYERS
3.6.5 RIVALRY AMONG EXISTING COMPETITORS
3.7 SUPPLY CHAIN ANALYSIS
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.9 SURGICAL SEALANTS AND ADHESIVES COMPANY COMPARISON BY PRODUCT TYPE, MATERIAL, PRODUCT NAME AND APPLICATIONS
3.10 MARKET PENETRATION OF SURGICAL SEALANTS AND ADHESIVES IN SURGICAL WOUND CLOSURE MARKET
4 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 NATURAL SURGICAL SEALANTS AND ADHESIVES
4.2.1 FIBRIN
4.2.2 COLLAGEN
4.2.3 GELATIN
4.2.4 ALBUMIN
4.2.5 OTHERS
4.3 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES
4.3.1 CYANOACRYLATE
4.3.2 HYDROGEL
4.3.3 OTHERS
5 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 CARDIOVASCULAR SURGERY
5.3 GENERAL SURGERY
5.4 ORTHOPAEDIC SURGERY
5.5 UROLOGY
5.6 PULMONOLOGY
5.7 NEUROSURGERY
5.8 GYNAECOLOGY
5.9 COSMETIC SURGERY
5.10 OTHERS
6 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTERS
6.4 OTHERS
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 OTHERS
7.3 EUROPE
7.3.1 GERMANY
7.3.2 U.K.
7.3.3 FRANCE
7.3.4 OTHERS
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 OTHERS
7.5 ROW
7.5.1 BRAZIL
7.5.2 REST OF LATIN AMERICA
7.5.3 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 APPROVALS
8.3 AGREEMENT
8.4 ACQUISITIONS
8.5 NEW PRODUCT LAUNCH
8.6 OTHER DEVELOPMENTS
9 MAJOR COMPANIES
9.1 ADVANCED MEDICAL SOLUTIONS GROUP PLC
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 BAXTER INTERNATIONAL, INC
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 B.BRAUN MELSUNGEN AG
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 BECTON, DICKINSON AND COMPANY (C.R.BARD INC.)
9.4.1 OVERVIEW
9.4.2 FINANCIALS*
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 COHERA MEDICAL, INC.
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 CRYOLIFE, INC.
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 JOHNSON & JOHNSON (ETHICON)
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 MALLINCKRODT PLC
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 MEDTRONIC PLC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 TAKEDA PHARMACEUTICAL COMPANY LTD.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 22
Table 2 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 82
Table 3 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 85
Table 4 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 87
Table 5 FIBRIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 90
Table 6 COLLAGEN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 93
Table 7 GELATIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 96
Table 8 ALBUMIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 99
Table 9 OTHER NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 102
Table 10 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 105
Table 11 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 107
Table 12 CYANOACRYLATE GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 110
Table 13 HYDROGEL GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 113
Table 14 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 116
Table 15 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN) 119
Table 16 CARDIOVASCULAR SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 122
Table 17 GENERAL SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 125
Table 18 ORTHOPAEDIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 128
Table 19 UROLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 131
Table 20 PULMONOLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 134
Table 21 NEUROSURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 137
Table 22 GYNAECOLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 140
Table 23 COSMETIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 143
Table 24 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 146
Table 25 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY END-USERS, (2016-2024) ($MN) 149
Table 26 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 152
Table 27 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 155
Table 28 OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 158
Table 29 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 161
Table 30 NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 164
Table 31 NORTH AMERICA NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 165
Table 32 NORTH AMERICA SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 166
Table 33 NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN) 167
Table 34 NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN) 168
Table 35 NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN) 171
Table 36 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 179
Table 37 EUROPE NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 180
Table 38 EUROPE SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 181
Table 39 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN) 182
Table 40 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN) 183
Table 41 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN) 186
Table 42 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 200
Table 43 APAC NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 201
Table 44 APAC SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 202
Table 45 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN) 203
Table 46 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN) 204
Table 47 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN) 207
Table 48 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN) 221
Table 49 ROW NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 222
Table 50 ROW SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 223
Table 51 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN) 224
Table 52 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN) 225
Table 53 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN) 228
Table 54 APPROVALS (2015 - 2018) 239
Table 55 AGREEMENT (2015 - 2018) 241
Table 56 ACQUISITIONS (2015 - 2018) 243
Table 57 NEW PRODUCT LAUNCH (2015 - 2018) 244
Table 58 OTHER DEVELOPMENTS (2015 - 2018) 245
Table 59 ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 247
Table 60 ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 248
Table 61 ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 249
Table 62 BAXTER INTERNATIONAL, INC.: TOTAL SALES AND R&D EXPENSES, (2015-2017) ($MN) 253
Table 63 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY SEGMENTS, (2015-2017) ($MN) 254
Table 64 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY GEOGRAPHY, (2015-2017) ($MN) 255
Table 65 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN) 260
Table 66 B.BRAUN MELSENGEN AG: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 261
Table 67 B.BRAUN MELSENGEN, AG: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 262
Table 68 C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 266
Table 69 C.R.BARD INC: TOTAL REVENUE BY SEGMENTS, (2015-17) ($MN) 267
Table 70 C.R. BARD: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 268
Table 71 CRYOLIFE, INC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 277
Table 72 CRYOLIFE, INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 278
Table 73 CRYOLIFE, INC: TOTAL REVENUE, BY PRODUCTS, (2015-2017) ($MN) 279
Table 74 CRYOLIFE, INC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 280
Table 75 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 285
Table 76 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 286
Table 77 JOHNSON & JOHNSON: TOTAL REVENUE, BY MEDICAL DEVICES SEGMENTS, (2015-2017) ($MN) 287
Table 78 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 288
Table 79 MALLINCKRODT PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 293
Table 80 MALLINCKRODT PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 294
Table 81 MALLINCKRODT PLC: TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN) 295
Table 82 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 300
Table 83 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 301
Table 84 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 302
Table 85 TAKEDA PHARMACEUTICAL COMPANY LTD: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 306
Table 1 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 22
Table 2 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 82
Table 3 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 85
Table 4 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 87
Table 5 FIBRIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 90
Table 6 COLLAGEN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 93
Table 7 GELATIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 96
Table 8 ALBUMIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 99
Table 9 OTHER NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 102
Table 10 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 105
Table 11 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 107
Table 12 CYANOACRYLATE GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 110
Table 13 HYDROGEL GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 113
Table 14 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 116
Table 15 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN) 119
Table 16 CARDIOVASCULAR SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 122
Table 17 GENERAL SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 125
Table 18 ORTHOPAEDIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 128
Table 19 UROLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 131
Table 20 PULMONOLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 134
Table 21 NEUROSURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 137
Table 22 GYNAECOLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 140
Table 23 COSMETIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 143
Table 24 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 146
Table 25 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY END-USERS, (2016-2024) ($MN) 149
Table 26 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 152
Table 27 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 155
Table 28 OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 158
Table 29 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN) 161
Table 30 NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 164
Table 31 NORTH AMERICA NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 165
Table 32 NORTH AMERICA SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 166
Table 33 NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN) 167
Table 34 NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN) 168
Table 35 NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN) 171
Table 36 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 179
Table 37 EUROPE NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 180
Table 38 EUROPE SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 181
Table 39 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN) 182
Table 40 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN) 183
Table 41 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN) 186
Table 42 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 200
Table 43 APAC NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 201
Table 44 APAC SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 202
Table 45 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN) 203
Table 46 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN) 204
Table 47 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN) 207
Table 48 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN) 221
Table 49 ROW NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 222
Table 50 ROW SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN) 223
Table 51 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN) 224
Table 52 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN) 225
Table 53 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN) 228
Table 54 APPROVALS (2015 - 2018) 239
Table 55 AGREEMENT (2015 - 2018) 241
Table 56 ACQUISITIONS (2015 - 2018) 243
Table 57 NEW PRODUCT LAUNCH (2015 - 2018) 244
Table 58 OTHER DEVELOPMENTS (2015 - 2018) 245
Table 59 ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 247
Table 60 ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 248
Table 61 ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 249
Table 62 BAXTER INTERNATIONAL, INC.: TOTAL SALES AND R&D EXPENSES, (2015-2017) ($MN) 253
Table 63 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY SEGMENTS, (2015-2017) ($MN) 254
Table 64 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY GEOGRAPHY, (2015-2017) ($MN) 255
Table 65 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN) 260
Table 66 B.BRAUN MELSENGEN AG: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 261
Table 67 B.BRAUN MELSENGEN, AG: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 262
Table 68 C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 266
Table 69 C.R.BARD INC: TOTAL REVENUE BY SEGMENTS, (2015-17) ($MN) 267
Table 70 C.R. BARD: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 268
Table 71 CRYOLIFE, INC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 277
Table 72 CRYOLIFE, INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 278
Table 73 CRYOLIFE, INC: TOTAL REVENUE, BY PRODUCTS, (2015-2017) ($MN) 279
Table 74 CRYOLIFE, INC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 280
Table 75 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 285
Table 76 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 286
Table 77 JOHNSON & JOHNSON: TOTAL REVENUE, BY MEDICAL DEVICES SEGMENTS, (2015-2017) ($MN) 287
Table 78 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 288
Table 79 MALLINCKRODT PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 293
Table 80 MALLINCKRODT PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 294
Table 81 MALLINCKRODT PLC: TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN) 295
Table 82 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 300
Table 83 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 301
Table 84 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 302
Table 85 TAKEDA PHARMACEUTICAL COMPANY LTD: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 306
LIST OF FIGURES
Figure 1 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN) 23
Figure 2 RESEARCH METHODOLOGY: SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET 29
Figure 3 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 30
Figure 4 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: FORECASTING MODEL 31
Figure 5 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION 32
Figure 6 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SEGMENTATION 39
Figure 7 MARKET DYNAMICS 40
Figure 8 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: PORTER’S ANALYSIS 57
Figure 9 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS 61
Figure 10 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%) 65
Figure 11 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET PENETRATION, BY APPLICATION (2017) (%) 80
Figure 12 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2016 - 2024) ($MN) 83
Figure 13 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2017 V/S 2024) ($MN) 86
Figure 14 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 88
Figure 15 FIBRIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 91
Figure 16 COLLAGEN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 94
Figure 17 GELATIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 97
Figure 18 ALBUMIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 100
Figure 19 OTHER NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 103
Figure 20 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2017 V/S 2024) ($MN) 106
Figure 21 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 108
Figure 22 CYANOACRYLATE GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 111
Figure 23 HYDROGEL GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 114
Figure 24 OTHERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 117
Figure 25 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY APPLICATION, (2017 V/S 2024) ($MN) 120
Figure 26 CARDIOVASCULAR SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 123
Figure 27 GENERAL SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 126
Figure 28 ORTHOPAEDIC SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 129
Figure 29 UROLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 132
Figure 30 PULMONOLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 135
Figure 31 NEUROSURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 138
Figure 32 GYNAECOLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 141
Figure 33 COSMETIC SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 144
Figure 34 OTHER APPLICATIONS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 147
Figure 35 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY END-USERS, (2017 V/S 2024) ($MN) 150
Figure 36 HOSPITALS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 153
Figure 37 AMBULATORY SURGICAL CENTERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 156
Figure 38 OTHER END-USERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 159
Figure 39 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN), CAGR (%) 162
Figure 40 NORTH AMERICA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 169
Figure 41 NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 170
Figure 42 U.S. SURGICAL S & A MARKET REVENUE, BY PRODUCT/END-USER, NATURAL AND SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 173
Figure 43 U.S. SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 174
Figure 44 OTHER NORTH AMERICA COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 176
Figure 45 OTHER NORTH AMERICA COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 177
Figure 46 EUROPE SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 184
Figure 47 EUROPE SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 185
Figure 48 GERMANY SURGICAL S & A REVENUE, BY PRODUCT/END-USER NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 188
Figure 49 GERMANY SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 189
Figure 50 U.K. SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 191
Figure 51 U.K. SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 192
Figure 52 FRANCE SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 194
Figure 53 FRANCE SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 195
Figure 54 OTHER EUROPE COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 197
Figure 55 OTHER EUROPE COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 198
Figure 56 APAC SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 205
Figure 57 APAC SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 206
Figure 58 JAPAN SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 209
Figure 59 JAPAN SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 210
Figure 60 CHINA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 212
Figure 61 CHINA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 213
Figure 62 INDIA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 215
Figure 63 INDIA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 216
Figure 64 OTHER APAC COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 218
Figure 65 OTHER APAC COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 219
Figure 66 ROW SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 226
Figure 67 ROW SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 227
Figure 68 BRAZIL SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 230
Figure 69 BRAZIL SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 231
Figure 70 REST OF LATIN AMERICA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 233
Figure 71 REST OF LATIN AMERICA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 234
Figure 72 MIDDLE EAST AND OTHER ROW COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 236
Figure 73 MIDDLE EAST AND OTHER ROW COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 237
Figure 74 KEY GROWTH STRATEGIES, (2015-2018) 238
Figure 75 SWOT: ADVANCED SOLUTIONS GROUP PLC 251
Figure 76 SWOT: BAXTER INTERNATIONAL, INC. 258
Figure 77 SWOT: B.BRAUN MELSUNGEN, AG 264
Figure 78 SWOT: BD (C.R.BARD, INC.) 271
Figure 79 SWOT: COHERA MEDICAL, INC. 275
Figure 80 SWOT: CRYOLIFE, INC. 283
Figure 81 SWOT: JOHNSON & JOHNSON (ETHICON) 291
Figure 82 SWOT: MALLINCKRODT PLC 298
Figure 83 SWOT: MEDTRONIC, PLC 304
Figure 84 SWOT: TAKEDA PHARMACEUTICAL COMPANY LTD. 308
Figure 1 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN) 23
Figure 2 RESEARCH METHODOLOGY: SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET 29
Figure 3 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 30
Figure 4 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: FORECASTING MODEL 31
Figure 5 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION 32
Figure 6 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SEGMENTATION 39
Figure 7 MARKET DYNAMICS 40
Figure 8 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: PORTER’S ANALYSIS 57
Figure 9 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS 61
Figure 10 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%) 65
Figure 11 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET PENETRATION, BY APPLICATION (2017) (%) 80
Figure 12 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2016 - 2024) ($MN) 83
Figure 13 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2017 V/S 2024) ($MN) 86
Figure 14 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 88
Figure 15 FIBRIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 91
Figure 16 COLLAGEN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 94
Figure 17 GELATIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 97
Figure 18 ALBUMIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 100
Figure 19 OTHER NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 103
Figure 20 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2017 V/S 2024) ($MN) 106
Figure 21 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 108
Figure 22 CYANOACRYLATE GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 111
Figure 23 HYDROGEL GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 114
Figure 24 OTHERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 117
Figure 25 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY APPLICATION, (2017 V/S 2024) ($MN) 120
Figure 26 CARDIOVASCULAR SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 123
Figure 27 GENERAL SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 126
Figure 28 ORTHOPAEDIC SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 129
Figure 29 UROLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 132
Figure 30 PULMONOLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 135
Figure 31 NEUROSURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 138
Figure 32 GYNAECOLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 141
Figure 33 COSMETIC SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 144
Figure 34 OTHER APPLICATIONS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 147
Figure 35 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY END-USERS, (2017 V/S 2024) ($MN) 150
Figure 36 HOSPITALS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 153
Figure 37 AMBULATORY SURGICAL CENTERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 156
Figure 38 OTHER END-USERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%) 159
Figure 39 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN), CAGR (%) 162
Figure 40 NORTH AMERICA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 169
Figure 41 NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 170
Figure 42 U.S. SURGICAL S & A MARKET REVENUE, BY PRODUCT/END-USER, NATURAL AND SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 173
Figure 43 U.S. SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 174
Figure 44 OTHER NORTH AMERICA COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 176
Figure 45 OTHER NORTH AMERICA COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 177
Figure 46 EUROPE SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 184
Figure 47 EUROPE SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 185
Figure 48 GERMANY SURGICAL S & A REVENUE, BY PRODUCT/END-USER NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 188
Figure 49 GERMANY SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 189
Figure 50 U.K. SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 191
Figure 51 U.K. SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 192
Figure 52 FRANCE SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 194
Figure 53 FRANCE SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 195
Figure 54 OTHER EUROPE COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 197
Figure 55 OTHER EUROPE COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 198
Figure 56 APAC SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 205
Figure 57 APAC SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 206
Figure 58 JAPAN SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 209
Figure 59 JAPAN SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 210
Figure 60 CHINA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 212
Figure 61 CHINA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 213
Figure 62 INDIA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 215
Figure 63 INDIA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 216
Figure 64 OTHER APAC COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 218
Figure 65 OTHER APAC COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 219
Figure 66 ROW SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 226
Figure 67 ROW SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 227
Figure 68 BRAZIL SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 230
Figure 69 BRAZIL SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 231
Figure 70 REST OF LATIN AMERICA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 233
Figure 71 REST OF LATIN AMERICA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 234
Figure 72 MIDDLE EAST AND OTHER ROW COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN) 236
Figure 73 MIDDLE EAST AND OTHER ROW COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN) 237
Figure 74 KEY GROWTH STRATEGIES, (2015-2018) 238
Figure 75 SWOT: ADVANCED SOLUTIONS GROUP PLC 251
Figure 76 SWOT: BAXTER INTERNATIONAL, INC. 258
Figure 77 SWOT: B.BRAUN MELSUNGEN, AG 264
Figure 78 SWOT: BD (C.R.BARD, INC.) 271
Figure 79 SWOT: COHERA MEDICAL, INC. 275
Figure 80 SWOT: CRYOLIFE, INC. 283
Figure 81 SWOT: JOHNSON & JOHNSON (ETHICON) 291
Figure 82 SWOT: MALLINCKRODT PLC 298
Figure 83 SWOT: MEDTRONIC, PLC 304
Figure 84 SWOT: TAKEDA PHARMACEUTICAL COMPANY LTD. 308
